首页> 美国卫生研究院文献>British Journal of Clinical Pharmacology >Effect of quinidine on plasma concentration and renal clearance of digoxin. A clinically important drug interaction.
【2h】

Effect of quinidine on plasma concentration and renal clearance of digoxin. A clinically important drug interaction.

机译:奎尼丁对地高辛血药浓度和肾脏清除率的影响。临床上重要的药物相互作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1 Thirty patients on maintenance digoxin therapy and admitted for cardioversion of atrial fibrillation were closely monitored with regard to plasma levels of digoxin and quinidine. 2 Seventeen of these patients were kept on maintenance digoxin therapy. After an initial lag period of 6 to 18 h after the addition of quinidine their digoxin levels started to increase and had increased by between 20 and 330% after 3 days on quinidine. Side-effects attributed to the raised digoxin concentration occurred in 6 of these patients. 3 As studied in 5 of these 17 patients the renal clearance of digoxin decreased markedly when quinidine was added to the therapy. There was also a slight but significant reduction in creatinine clearance (n = 4). 4 In 13 patients digoxin was discontinued 36 h prior to the first quinidine dose. Also in these patients digoxin plasma levels increased significantly. 5 It is concluded that quinidine causes an unpredictably large increase in plasma digoxin and that this effect is probably at least initially to a large part due to a redistribution of digoxin in the body. The relative contributions of re-distribution and impaired renal clearance of digoxin to the increase in digoxin steady-state levels are presently unknown. 6 It is recommended that close monitoring of digoxin concentration and appropriate reduction of the maintenance dose is undertaken when quinidine is to be given to patients on digitalis therapy.
机译:1 30名接受维持性地高辛治疗并因心房颤动复律而入院的患者接受了血浆地高辛和奎尼丁水平的密切监测。 2这些患者中有17名接受了维持性地高辛治疗。在加入奎尼丁后的最初滞后6至18小时后,它们的地高辛水平开始增加,在奎尼丁3天后,地高辛水平增加了20%至330%。这些患者中有6位发生了归因于地高辛浓度升高的副作用。 3如在这17名患者中的5名中研究的,将奎尼丁加入治疗后,地高辛的肾脏清除率显着降低。肌酐清除率也有轻微但显着的降低(n = 4)。 4在13例患者中,地高辛在第一个奎尼丁剂量前36小时停药。在这些患者中,地高辛的血浆水平也显着增加。 5结论是奎尼丁会导致血浆地高辛的大量增加,而且这种作用可能至少在最初起很大程度是由于地高辛在体内的重新分布。地高辛的重新分布和肾清除率受损对地高辛稳态水平增加的相对贡献目前未知。 6建议对洋地黄治疗的患者使用奎尼丁时,应密切监测地高辛的浓度并适当降低维持剂量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号